Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 28 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 4 pages · English

Summary by 6ix AI

The product will be marketed under the brand names Sigrima by Zydus and Womab by Dr. Reddy’s. Zydus will receive upfront licensing income and milestone payments based on the achievement of specific targets.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Zydus and Dr. Reddy s announce licensing agreement for co-marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases